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Abstract
Photodynamic therapy (PDT) of cancer is a promising technique based on the formation of singlet oxygen following
irradiation of a sensitizer with visible light. In the present work we investigated the role of calpains in PDT, using the human
lymphoblastoid CCRF-CEM cells and bisulfonated aluminum phthalocyanine (AlPcS2) as a sensitizer. Photosensitization
induced apoptotic cell death and a time-dependent activation of calpains, as determined using the fluorogenic substrate
succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin (SLLVY-AMC). However, inhibition of calpains with calpain inhibitor
II or with PD 150606 did not affect the demise process. The results indicate that although calpains are activated in PDT, they do
not play a major role in tumor cell death.
q 2004 Elsevier Ireland Ltd. All rights reserved.
Keywords: Photodynamic therapy; Calpains; Caspases; Apoptosis1. Introduction
Photodynamic therapy (PDT) of cancer is based on
the tumor-specific accumulation of a photosensitizer,
followed by irradiation with visible light, which
induces cell death and tumor ablation. Photofrin, the
first photosensitizer approved for human use, has been
successfully employed in the treatment of lung,
esophageal, cervical, bladder and gastric tumors, but
a second generation of photosensitizers have attained
approval for treatment of various cancers in Europe0304-3835/$ - see front matter q 2004 Elsevier Ireland Ltd. All rights re
doi:10.1016/j.canlet.2004.07.006
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E-mail address: cbduarte@ci.uc.pt (C.B. Duarte).and Japan [1–3]. PDT induces a rapid apoptotic
response in tumor cells (e.g. [4,5]), and the release of
cytochrome C from mitochondria and consequent
activation of a cascade of apoptosis-mediating
caspases have been described in photosensitized
cells (reviewed in Refs. [6,7]). However, the mech-
anism leading to the induction of apoptosis in
photosensitized cells is not fully understood.
Calpains are ubiquitous Ca2C-dependent intra-
cellular cysteine proteases. Two major calpains were
identified, m-calpain (calpain I) and m-calpain
(calpain II), which differ in the Ca2C concentration
required for maximal activity. Both classes of calpains
are regulated by a specific endogenous inhibitor,
calpastatin (reviewed in Ref. [8]). Although calpain
activation during apoptosis has been observed inCancer Letters 216 (2004) 183–189www.elsevier.com/locate/canletserved.
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of these proteases in the demise process is contro-
versial. In fact, inhibition of calpains was shown to
have no effect (e.g. [9,10]), to increase (e.g. [10–14])
and to reduce (e.g. [10,15–19]) apoptosis. Even in the
same cell line the role of calpains in apoptosis can
vary depending on the type of insult (e.g. [10]),
suggesting that the diversity of effects that have been
reported may arise, at least in part, from differences in
the initial intracellular signals generated by the toxic
insult. Another level of complexity may result from
the cross-talk between the caspase and calpain
proteolytic systems [13,20–25].
Photodynamic treatment of various tumor cell
types has been shown to raise the [Ca2C]i, due to
Ca2C entry through ion channels (e.g. [26]), release of
Ca2C sequestered in internal stores (e.g. [27–29]),
and/or activation of ion exchange mechanisms ([30];
see also Ref. [7] for a review). The increase in the
[Ca2C]i was shown to play an important role in the
demise process, using various sensitizers and cell
types [31,32]. Since Ca2C activates calpains, we
investigated a putative role for these proteases in
PDT, using CCRF-CEM cells and bisulfonated
aluminum phthalocyanine (AlPcS2) as a sensitizer.
We have previously shown that photosensitization of
CCRF-CEM cells with AlPcS2 induces cell death by
apoptosis, characterized by chromatin condensation,
cleavage of caspases -3 and -9, and DNA fragmenta-
tion [5].2. Materials and methods
2.1. Materials
The human lymphoblastoid CCRF-CEM cells were
obtained from American Type Culture Collection
(Manassas, VA), and fetal calf serum was from
Biochrom (Berlin, Germany). AlPcS2 was a gift from
Dr Johan E. Van Lier (University of Sherbrooke,
Quebec, Canada). Ionomycin, PD 150606 and calpain
inhibitor II were purchased from Calbiochem (La Jolla,
CA). SYTO-13 and propidium iodide were from
Molecular Probes (Leiden, The Netherlands) and
Carbobenzoxy-Val-Ala-Asp(Ome)-FMK (Z-VAD-
FMK) was from Enzyme Systems Products (Livermore,
CA). Suc-Leu-Leu-Val-Tyr-AMC (SLLVY-AMC)was purchased from Bachem (Bubendorf, Switzerland).
All other chemicals were from Sigma (Sintra, Portugal)
or Merck (Darmstadt, Germany).2.2. Cell culture
CCRF-CEM cells were cultured in RPMI-1640
medium supplemented with 10% fetal calf serum,
23.8 mM NaHCO3 and penicillin–streptomycin
(50 U/ml and 50 mg/ml), in a 95% air and 5% CO2
atmosphere.2.3. PDT treatment
Cells (0.5!106 cells/ml) were incubated with
5 mM AlPcS2 for 18 h. After centrifugation the pellet
was resuspended in fresh culture medium, at the
initial concentration. Cells were then irradiated with
visible light using a cut off filter (!600 nm), with a
fluence rate of 30 mW/cm2, and a total light dose of
15 J/cm2, as previously described [33]. The cells were
then centrifuged and incubated in culture medium for
3 h before quantification of cell death or calpain
activity.2.4. Quantification of apoptotic cell death
Cells were washed and resuspended in NaC salt
solution (in mM: 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2,
5.5 Glucose, 15 N-2-hydroxyethylpiperazine-N 0-2-
ethanesulfonic acid [HEPES], pH 7.4) supplemented
with 200 nM SYTO-13 and 1.6 mg/ml propidium
iodide. Apoptotic nuclei were scored under a
fluorescence microscope using a triple-wavelength
filter set (XF 63; Omega Optical, Brattleboro, VT).2.5. Measurement of calpain activity
The cells (1!106) were centrifuged, and the pellet
was then resuspended in 2 ml of NaC medium. The
fluorogenic substrate of calpains SLLVY-AMC was
added to the cuvette, at a final concentration of
200 mM, and the cell suspensions were then main-
tained at 37 8C. The AMC fluorescence was measured
every 5 min, at 37 8C, using a SPEX Fluoromax
spectrofluorometer (lexZ380 nm; lemZ460 nm).
Fig. 1. Inhibition of PDT-induced apoptotic death by the caspase
inhibitor Z-VAD-FMK. CCRF-CEM cells were subjected or not
(control) to PDT with AlPcS2, as indicated in the methods
section, and apoptotic morphology was evaluated by double
staining, with propidium iodide and SYTO-13, 3 h after
irradiation. Where indicated the cells were pre-incubated with
10 or 100 mM Z-VAD-FMK, for 1 h, before photosensitization,
and maintained in the presence of the inhibitor until cell death
was measured. The results are the averageGSEM of three
independent experiments. Statistical significance was determined
using the One Way ANOVA followed by the Tukey’s multiple
comparison test: ***P!0.001, as compared with the control, or
CCP!0.01 and CCCP!0.001, as compared with photosensi-
tized cells in the absence of Z-VAD-FMK.
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Statistical significance was determined using the
two-tailed Student’s t-test or the One Way ANOVA
followed by the Tukey’s multiple comparison, as
indicated.3. Results
The role of capains in cell induced by PDT was
investigated using CCRF-CEM cells, and AlPcS2 as a
sensitizer. The cells were pre-incubated with the
sensitizer for 18 h before irradiation, and cell death
was measured 3 h after irradiation with a fluence rate
of 30 mW/cm2, and a total light dose of 15 J/cm2, by
double staining with SYTO-13 and propidium iodide.
Under these conditions we observed that about 50%
(Fig. 1, AlPcS2) of the cells exhibited the characteristicapoptotic morphology. The number of necrotic cells
was less than 5%, as in the control (not shown).
Incubation of the cells with a general caspase
inhibitor, Z-VAD-FMK [34], prevented cell death in
a dose-dependent manner. The number of apoptotic
cells found when photosensitization was performed in
the presence of 100 mM Z-VAD-FMK was not
significantly different from the control (PO0.05).
In order to determine whether PDT with AlPcS2
increase calpain activity in CCRF-CEM cells we
used the fluorogenic calpain substrate SLLVY-AMC
[35,36]. Control experiments showed that the Ca2C-
ionophore ionomycin (10 mM) rapidly increased the
rate of hydrolysis of SLLVY-AMC, as expected for a
calpain substrate (Fig. 2A). The activity of calpains in
photosensitized cells was measured by the rate of
SLLVY-AMC cleavage, at different periods of time
following irradiation. In each case the enzyme activity
was followed for at least 20 min (Fig. 2C) and the
results show that the rate of substrate hydrolysis
increased upon photosensitization, after a lag-phase of
about 2 h (Fig. 2B). Inhibition of calpains with
Calpain Inhibitor II (CI II; [37]) substantially reduced
the hydrolysis of the peptide by photosensitized cells,
to levels below those determined in control cells
(Fig. 2D). Control experiments showed that
irradiation of cells free of AlPcS2 did not affect
SLLVY-AMC cleavage (PO0.05), but the enzyme
activity under these conditions was still sensitive to
the effect of CI II. These results indicate that there is a
certain level of calpain activity under resting
conditions.
The role of calpains in PDT was evaluated using
the calpain inhibitors CI II and PD150606 [36]. None
of the inhibitors affected the death of CCRF-CEM
cells sensitized with AlPcS2 when measured 3 h after
the irradiation (Fig. 3), although at this point a
significant increase in the cleavage of the calpain
subtrate was observed (Fig. 2B).4. Discussion
In this work we show that photosensitization of
CCRF-CEM cells with AlPcS2 activated calpains and
rapidly induced apoptotic cell death, but inhibition of
calpains did not affect significantly the demise
process.
Fig. 2. PDT with AlPcS2 stimulates the cleavage of the calpain substrate SLLVY-AMC. (A) After addition of SLLVY-AMC (200 mM) CCRF-
CEM cells were stimulated with 10 mM ionomycin, and the fluorescence of the AMC group cleaved from the substrate was measured as
indicated in the methods section. (B) Control or photosensitized cells (AlPcS2) were incubated in culture medium, for the indicated period of
time, before measuring SLLVY-AMC cleavage activity. AMC fluorescence was measured every 5 min, and the cleavage of the substrate was
linear over a 20 min period. The results show the slope of the straight line resulting from the fit of experimental data points of SLLVY-AMC
cleavage, and are the average G SEM of 3–5 independent experiments. Panel C shows the changes in fluorescence intensity in suspensions of
control and PDT-treated cells, 5 h after photosensitization, and the results are the average G SEM of 4 independent experiments. (D) AMC
fluorescence (a.u.) resulting from the cleavage of SLLVY-AMC by control cells, irradiated (light) or not, and by cells subjected to PDT with
AlPcS2. Enzyme activity was measured 3 h after irradiation. Incubation with the substrate was performed for 15 min. Where indicated the cells
were pre-incubated with calpain inhibitor II before irradiaton, for 2 h, and the inhibitor was also added to the incubation medium after
irradiation. The results are the average G SEM of 3–5 independent experiments. Statistical significance was determined using the One Way
ANOVA followed by the Tukey’s multiple comparison test (D) or the two-tailed Student’s t-test (B, C). *P!0.05, **P!0.01, ***P!0.001, as
compared with the control. CCCP!0.001, as compared with photosensitized cells in the absence of CI II.
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changes in the nuclear morphology is in agreement
with our previous findings, showing that photosensi-
tization of CCRF-CEM cells with AlPcS2 induces cell
death by apoptosis, characterized by chromatin
condensation, cleavage of caspases-3 and -9, and
DNA fragmentation [5]. This cascade of events may
be subjected to regulation by calpains at different
levels. Indeed, caspase-9 is truncated by calpains,giving rise to the p35 polypeptide that has no ability to
activate caspase-3 [22,23]. Calpains also cleave
APAF-1, which forms the apoptosome together with
dATP, cytochrome C released from the mitochondria
and caspase-9 [38]. Furthermore, calpain-mediated
cleavage of caspase-3 to a p30 polypeptide enhanced
its activity in one case and reduced activation in
another [22,24,25]. Although these evidences indicate
that calpains may act as negative regulators of nuclear
Fig. 3. Calpain inhibitors have no effect on PDT-induced apoptotic
cell death. The cells were photosensitized with AlPcS2 as indicated
in the methods section, and where indicated were pre-incubated
with calpain inhibitor II (50 or 100 mM) (A) or with PD 150606 (10
or 50 mM) for 2 h before irradiation (B). When the effect of calpain
inhibitors was tested they were also present during photosensitiza-
tion as well as during the following 3 h, before measuring cell death.
The results are the average G SEM of 4–6 independent
experiments. ***P!0.001, as compared with the control.
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activation, our results show that this is not the case in
CCRF-CEM cells sensitized with AlPcS2. The lack of
effect of calpains on the demise process may be due to
an insufficient activation of the enzyme and/or to the
localization of calpains within the cells, which may be
unfavorable to interaction with proteins of the
apoptotic pathway.
The lack of effect of calpain inhibitors on PDT-
induced apoptotic cell death reported here alsocontrasts with results showing that calpain plays an
active role in apoptosis [10,15–19]. Cleavage of
X-linked inhibitor of apoptosis (XIAP) by calpains
produces fragments that are unable to inhibit caspase-
3, and this was suggested to contribute to the
inhibition of apoptosis in neurophils [14]. Calpains
may also contribute to apoptosis by cleaving Bid,
thereby generating a fragment able to trigger cyto-
chrome C release from mitochondria [18,19,39].
Furthermore, calpains cleave Bax at its N-terminal
region, generating a potent pro-apoptotic fragment,
and one study has reported a reduction in cell death
when Bax cleavage was prevented with a calpain
inhibitor [17]. In contrast, although inhibition of
calpains prevented Bax cleavage in neurons and
HL-60 cells, stimulated with the apoptotic agents
staurosporin and 9-AC (topoisomerase I inhibitor),
respectively, it was without effect on cell death [9,40].
However, Bax protein levels remained unaltered in
various cell lines subjected to PDT with the silicon
phthalocyanine Pc4 [41], 9-capronyloxy-tetrakis
(methoyxyethyl) porphycene (CPO), meta-tetra-
hydroxyphenyl chlorin (mTHPC), tin etiopurpurin
[42] and verteporfin [43]. Also, photosensitization of
the T cell hybridoma PC60R1R2 with hypericin did
not change Bid protein levels [44]. Therefore,
cleavage of Bid and Bax by calpains does not appear
to play an important role in PDT.
Calpains are proteases activated by Ca2C, and
since PDT increases the [Ca2C]i [26–30] this
mechanism is likely to contribute to the increase in
the activity of the enzyme observed in the present
work in CCRF-CEM cells photosensitized with
AlPcS2. However, there is also evidence that
caspases, including caspase-3, can promote calpain
activity through cleavage of calpastatin, the endogen-
ous protein inhibitor of calpains [20,21,45]. Since
caspase-3 is activated in CCRF-CEM cells subjected
to PDT with AlPcS2 [5] this may contribute, at least in
part, to the observed activation of calpains.
AlPcS2, the photosensitizer used in the present
work, has a diffuse distribution within the cells,
probably in the mitochondria [46]. Cell damage is
thought to arise from the action of reactive oxygen
species, primarily singlet oxygen, formed upon
interaction of light with the sensitizer. Since singlet
oxygen has a short half-life in cells, its intracellular
targets are close to the sites where the sensitizer is
R.D. Almeida et al. / Cancer Letters 216 (2004) 183–189188located [1]. Therefore, it is not surprising that PDT
with AlPcS2 induces a rapid apoptotic response
through the mitochondria mediated pathway [5].
Since the type of cellular response triggered by
activation of the photosensitizers depends on their
intracellular localization, it cannot be excluded a
possible role for calpains in apoptotic cell death in
PDT using other compounds.Acknowledgements
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